Market Currents
Neoprobe (NEOP -10.2%) fell sharply in afternoon trading on rumors an application for its...
-
Monday, October 17, 2011, 5:00 PM ETNeoprobe (NEOP -10.2%) fell sharply in afternoon trading on rumors an application for its Lymphoseek cancer-detection drug was rejected. However, shares are up 5.8% AH after a spokesperson says Neoprobe isn't aware of any news about its application, which the FDA is expected to decide upon by Oct. 24.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
